Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
MediciNova Inc
NASDAQ:MNOV
MediciNova Inc
NASDAQ:MNOV
Price:
1.675
USD
-12.76%
Market Cap:
$82.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
MediciNova Inc
NASDAQ:MNOV
|
US |
|
S
|
Swire Pacific Ltd
F:SWI
|
HK |
|
J
|
Jones Lang LaSalle Inc
SWB:4J2
|
US |
|
V
|
Verizon Communications Inc
DUS:BAC
|
US |
|
A
|
AbbVie Inc
BMV:ABBV
|
US |
|
M
|
Mid-America Apartment Communities Inc
F:M2K
|
US |
Wall St Price Targets
MNOV Price Forecast
Based on 5 analysts
Based on 5 analysts
+509% Upside
from
$1.675
today
MediciNova Inc (MNOV)’s 12-month stock price forecast through September 2027 has a consensus target of $10.2, implying 509% upside. The forecast is based on price targets from 5 Wall Street analysts.
MNOV Analyst Rating
Based on 2 analysts
Based on 2 analysts
Analysts rate MNOV Strong buy, with 2 of 2 recommending Buy or Strong buy.
MediciNova Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MNOV's stock price target?
Price Target
10.2
USD
10.2
USD
According to Wall Street analysts, the average 1-year price target for MNOV is 10.2 USD with a low forecast of 6.06 USD and a high forecast of 11.55 USD.
What is the Revenue forecast for MediciNova Inc?
Projected CAGR
142%
142%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 8 years is 142%.
What is the Gross Profit forecast for MediciNova Inc?
Projected CAGR
227%
227%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -22%. The projected CAGR for the next 8 years is 227%.